United States Healthcare Equipment & Supplies

Myomo Inc (MYO)

Track

Track

Myomo Inc. experienced six insider trading transactions over the past ninety days, resulting in a net negative value of approximately $51,046. All recorded activity involved sales or proposed divestments by executives and directors. This selling trend follows a recent earnings report where the company outperformed expectations by 30 percent.
Ticker: MYO Exchange: ASE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Myomo Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.5
Kovelman Harry Chief Medical Officer Officer
Transaction date
Sale
Price
56.90
Quantity 53,946 -19.3%
Value US$2,791,579
3.5
HARRY KOVELMAN Officer Officer
Transaction date
Proposed sale
Price
91.04
Quantity 39,907
Value US$592,746
2.9
Morris Milton Mayo Non-Executive Director
Transaction date
Sale
Price
351.66
Quantity 51,020 +31.8%
Value US$2,163,446
2.9
Morris Milton Mayo Director Non-Executive Director
Transaction date
Proposed sale
Price
1.41
Quantity 15,000
Value US$21,150
3.5
Kovelman Harry Chief Medical Officer Officer
Transaction date
Sale
Price
1.73
Quantity 17,250 -14.0%
Value US$29,896
3.5
HARRY KOVELMAN Officer Officer
Transaction date
Proposed sale
Price
1.73
Quantity 17,500
Value US$30,329
1.6
David Henry Officer Officer
Transaction date
Proposed sale
Price
1.09
Quantity 5,166
Value US$5,631
3.5
Harry Kovelman Officer Officer
Transaction date
Proposed sale
Price
1.20
Quantity 10,442
Value US$12,530
3.3
Micah Mitchell Officer Officer
Transaction date
Proposed sale
Price
1.20
Quantity 9,061
Value US$10,873
3.5
Harry Kovelman Officer Officer
Transaction date
Proposed sale
Price
1.33
Quantity 7,635
Value US$10,155
3.3
Micah Mitchell Officer Officer
Transaction date
Proposed sale
Price
1.33
Quantity 6,529
Value US$8,684
2.7
KIRK THOMAS F Non-Executive Director
Transaction date
Purchase
Price
1.27
Quantity 40,002 +6.1%
Value US$50,803
2.7
KIRK THOMAS F Non-Executive Director
Transaction date
Purchase
Price
0.99
Quantity 25,000 +4.0%
Value US$24,825
3.5
Kovelman Harry Chief Medical Officer Officer
Transaction date
Sale
Price
1.02
Quantity 11,536 -9.6%
Value US$11,734
3.5
HARRY KOVELMAN Officer Officer
Transaction date
Proposed sale
Price
1.02
Quantity 11,536
Value US$11,734
3.5
Kovelman Harry Chief Medical Officer Officer
Transaction date
Sale
Price
1.00
Quantity 20,464 -14.6%
Value US$20,505
3.5
HARRY KOVELMAN Officer Officer
Transaction date
Proposed sale
Price
1.00
Quantity 20,464
Value US$20,468
2.7
KIRK THOMAS F Non-Executive Director
Transaction date
Purchase
Price
0.91
Quantity 43,401 +7.4%
Value US$39,495
2.7
KIRK THOMAS F Non-Executive Director
Transaction date
Purchase
Price
0.91
Quantity 31,605 +5.7%
Value US$28,748
2.6
Manko Joseph M. Jr. Non-Executive Director
Transaction date
Purchase
Price
0.89
Quantity 30,367 +1.3%
Value US$26,960
2.6
Manko Joseph M. Jr. Non-Executive Director
Transaction date
Purchase
Price
0.86
Quantity 170,830 +8.1%
Value US$146,948
3.3
MICAH MITCHELL Officer Officer
Transaction date
Proposed sale
Price
0.86
Quantity 90,231
Value US$77,689
1.6
David Henry Officer Officer
Transaction date
Proposed sale
Price
0.71
Quantity 3,953
Value US$2,807
3.6
Getz Heather C Non-Executive Director
Transaction date
Purchase
Price
0.70
Quantity 20,000 +17.9%
Value US$13,972
2.7
KIRK THOMAS F Non-Executive Director
Transaction date
Purchase
Price
0.71
Quantity 72,000 +14.9%
Value US$51,113
3.6
Getz Heather C Non-Executive Director
Transaction date
Purchase
Price
0.73
Quantity 70,000 +167.6%
Value US$50,960
2.7
KIRK THOMAS F Non-Executive Director
Transaction date
Purchase
Price
0.72
Quantity 2,535 +0.5%
Value US$1,825
2.7
KIRK THOMAS F Non-Executive Director
Transaction date
Purchase
Price
0.72
Quantity 4,902 +1.0%
Value US$3,529
2.7
KIRK THOMAS F Non-Executive Director
Transaction date
Purchase
Price
1.15
Quantity 50,000 +11.8%
Value US$57,500
2.7
KIRK THOMAS F Non-Executive Director
Transaction date
Purchase
Price
1.10
Quantity 50,000 +13.4%
Value US$55,000
3.6
GUDONIS PAUL R Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.95
Quantity 50,000 +4.1%
Value US$47,295
3.5
Harry Kovelman Officer Officer
Transaction date
Proposed sale
Price
2.97
Quantity 5,743
Value US$17,057
1.6
David Henry Officer Officer
Transaction date
Proposed sale
Price
2.97
Quantity 8,373
Value US$24,868
2.7
KIRK THOMAS F Non-Executive Director
Transaction date
Purchase
Price
3.25
Quantity 36,824 +12.0%
Value US$119,678
3.6
GUDONIS PAUL R Chief Executive Officer Executive Director
Transaction date
Purchase
Price
3.22
Quantity 30,000 +2.9%
Value US$96,612
3.3
Mitchell Micah Chief Commercial Officer Officer
Transaction date
Sale
Price
0.86
Quantity 90,231 -45.2%
Value US$77,689
2.7
KIRK THOMAS F Non-Executive Director
Transaction date
Purchase
Price
3.25
Quantity 1,943 +0.6%
Value US$6,315
2.7
KIRK THOMAS F Non-Executive Director
Transaction date
Purchase
Price
3.35
Quantity 50,000 +19.5%
Value US$167,500
3.3
MICAH MITCHELL Officer Officer
Transaction date
Proposed sale
Price
5.16
Quantity 48,000
Value US$247,565
3.3
Mitchell Micah Chief Commercial Officer Officer
Transaction date
Sale
Price
5.16
Quantity 48,000 -25.5%
Value US$247,565
2.7
KIRK THOMAS F Non-Executive Director
Transaction date
Purchase
Price
5.00
Quantity 7,400 +3.0%
Value US$37,000
3.3
Micah Mitchell Officer Officer
Transaction date
Proposed sale
Price
5.22
Quantity 1,283
Value US$6,697
1.6
David Henry Officer Officer
Transaction date
Proposed sale
Price
5.22
Quantity 2,019
Value US$10,539
3.5
Harry Kovelman Officer Officer
Transaction date
Proposed sale
Price
5.22
Quantity 1,496
Value US$7,809
3.5
Kovelman Harry Chief Medical Officer Officer
Transaction date
Sale
Price
5.50
Quantity 30,000 -23.4%
Value US$165,018
3.5
HARRY KOVELMAN Officer Officer
Transaction date
Proposed sale
Price
5.50
Quantity 30,000
Value US$165,015
3.5
Harry Kovelman Officer Officer
Transaction date
Proposed sale
Price
3.70
Quantity 121
Value US$448
3.5
Harry Kovelman Officer Officer
Transaction date
Proposed sale
Price
3.86
Quantity 121
Value US$467
3.5
Kovelman Harry Chief Medical Officer Officer
Transaction date
Sale
Price
3.76
Quantity 6,700 -5.1%
Value US$25,183
3.5
Harry Kovelman Officer Officer
Transaction date
Proposed sale
Price
3.89
Quantity 139
Value US$541
3.5
Kovelman Harry Chief Medical Officer Officer
Transaction date
Sale
Price
4.01
Quantity 2,029 -1.5%
Value US$8,140
3.5
Harry Kovelman Officer Officer
Transaction date
Proposed sale
Price
4.00
Quantity 18,500
Value US$74,000
3.5
Harry Kovelman Officer Officer
Transaction date
Proposed sale
Price
3.96
Quantity 128
Value US$507
3.5
Harry Kovelman Officer Officer
Transaction date
Proposed sale
Price
2.85
Quantity 121
Value US$345
1.6
David Henry Officer Officer
Transaction date
Proposed sale
Price
3.02
Quantity 25,436
Value US$76,817
3.3
Micah Mitchell Officer Officer
Transaction date
Proposed sale
Price
3.02
Quantity 15,500
Value US$46,810
3.5
Harry Kovelman Officer Officer
Transaction date
Proposed sale
Price
3.02
Quantity 12,868
Value US$38,861
3.5
Harry Kovelman Officer Officer
Transaction date
Proposed sale
Price
3.39
Quantity 5,340
Value US$18,103
3.3
Micah Mitchell Officer Officer
Transaction date
Proposed sale
Price
3.39
Quantity 6,824
Value US$23,133
1.6
David Henry Officer Officer
Transaction date
Proposed sale
Price
3.39
Quantity 10,599
Value US$35,931
3.5
Harry Kovelman Officer Officer
Transaction date
Proposed sale
Price
3.41
Quantity 121
Value US$413
2.7
KIRK THOMAS F Non-Executive Director
Transaction date
Purchase
Price
3.50
Quantity 50,000 +26.8%
Value US$175,000
3.5
Kovelman Harry Chief Medical Officer Officer
Transaction date
Sale
Price
3.69
Quantity 35,426 -26.5%
Value US$130,839
3.5
HARRY KOVELMAN Officer Officer
Transaction date
Proposed sale
Price
3.69
Quantity 35,426
Value US$130,835
3.5
Harry Kovelman Officer Officer
Transaction date
Proposed sale
Price
3.92
Quantity 146
Value US$572
3.5
Harry Kovelman Officer Officer
Transaction date
Proposed sale
Price
3.03
Quantity 146
Value US$442
2.7
KIRK THOMAS F Non-Executive Director
Transaction date
Purchase
Price
3.50
Quantity 50,000 +36.6%
Value US$175,000
3.5
Harry Kovelman Officer Officer
Transaction date
Proposed sale
Price
3.19
Quantity 6,590
Value US$21,022
1.6
David Henry Officer Officer
Transaction date
Proposed sale
Price
3.19
Quantity 7,774
Value US$24,799
3.3
Micah Mitchell Officer Officer
Transaction date
Proposed sale
Price
3.19
Quantity 5,359
Value US$17,095
3.5
Harry Kovelman Officer Officer
Transaction date
Proposed sale
Price
3.86
Quantity 151
Value US$583
3.5
Harry Kovelman Officer Officer
Transaction date
Proposed sale
Price
3.40
Quantity 146
Value US$496
3.5
Harry Kovelman Officer Officer
Transaction date
Proposed sale
Price
4.79
Quantity 145
Value US$695
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-14 2026-09-11 S Sale
3.5
Kovelman Harry

Chief Medical Officer

Officer
53,946 -19.3%
56.90
US$2,791,579 		53,946 -19.3% 56.90 US$2,791,579
2026-09-11 2026-09-11 PrS Proposed sale
3.5
HARRY KOVELMAN

Officer

Officer
39,907
91.04
US$592,746 		39,907 91.04 US$592,746
2026-09-04 2026-09-02 S Sale
2.9
Morris Milton Mayo
Non-Executive Director
51,020 +31.8%
351.66
US$2,163,446 		51,020 +31.8% 351.66 US$2,163,446
2026-09-02 2026-09-02 PrS Proposed sale
2.9
Morris Milton Mayo

Director

Non-Executive Director
15,000
1.41
US$21,150 		15,000 1.41 US$21,150
2026-08-21 2026-08-20 S Sale
3.5
Kovelman Harry

Chief Medical Officer

Officer
17,250 -14.0%
1.73
US$29,896 		17,250 -14.0% 1.73 US$29,896
2026-08-20 2026-08-20 PrS Proposed sale
3.5
HARRY KOVELMAN

Officer

Officer
17,500
1.73
US$30,329 		17,500 1.73 US$30,329
2026-07-13 2026-07-13 PrS Proposed sale
1.6
David Henry

Officer

Officer
5,166
1.09
US$5,631 		5,166 1.09 US$5,631
2026-06-12 2026-06-12 PrS Proposed sale
3.5
Harry Kovelman

Officer

Officer
10,442
1.20
US$12,530 		10,442 1.20 US$12,530
2026-06-12 2026-06-12 PrS Proposed sale
3.3
Micah Mitchell

Officer

Officer
9,061
1.20
US$10,873 		9,061 1.20 US$10,873
2026-06-08 2026-06-08 PrS Proposed sale
3.5
Harry Kovelman

Officer

Officer
7,635
1.33
US$10,155 		7,635 1.33 US$10,155
2026-06-08 2026-06-08 PrS Proposed sale
3.3
Micah Mitchell

Officer

Officer
6,529
1.33
US$8,684 		6,529 1.33 US$8,684
2026-06-09 2026-06-05 B Purchase
2.7
KIRK THOMAS F
Non-Executive Director
40,002 +6.1%
1.27
US$50,803 		40,002 +6.1% 1.27 US$50,803
2026-06-01 2026-05-28 B Purchase
2.7
KIRK THOMAS F
Non-Executive Director
25,000 +4.0%
0.99
US$24,825 		25,000 +4.0% 0.99 US$24,825
2026-05-28 2026-05-28 S Sale
3.5
Kovelman Harry

Chief Medical Officer

Officer
11,536 -9.6%
1.02
US$11,734 		11,536 -9.6% 1.02 US$11,734
2026-05-28 2026-05-28 PrS Proposed sale
3.5
HARRY KOVELMAN

Officer

Officer
11,536
1.02
US$11,734 		11,536 1.02 US$11,734
2026-05-28 2026-05-27 S Sale
3.5
Kovelman Harry

Chief Medical Officer

Officer
20,464 -14.6%
1.00
US$20,505 		20,464 -14.6% 1.00 US$20,505
2026-05-27 2026-05-27 PrS Proposed sale
3.5
HARRY KOVELMAN

Officer

Officer
20,464
1.00
US$20,468 		20,464 1.00 US$20,468
2026-05-18 2026-05-18 B Purchase
2.7
KIRK THOMAS F
Non-Executive Director
43,401 +7.4%
0.91
US$39,495 		43,401 +7.4% 0.91 US$39,495
2026-05-18 2026-05-15 B Purchase
2.7
KIRK THOMAS F
Non-Executive Director
31,605 +5.7%
0.91
US$28,748 		31,605 +5.7% 0.91 US$28,748
2026-05-18 2026-05-15 B Purchase
2.6
Manko Joseph M. Jr.
Non-Executive Director
30,367 +1.3%
0.89
US$26,960 		30,367 +1.3% 0.89 US$26,960
2026-05-18 2026-05-14 B Purchase
2.6
Manko Joseph M. Jr.
Non-Executive Director
170,830 +8.1%
0.86
US$146,948 		170,830 +8.1% 0.86 US$146,948
2026-05-14 2026-05-14 PrS Proposed sale
3.3
MICAH MITCHELL

Officer

Officer
90,231
0.86
US$77,689 		90,231 0.86 US$77,689
2026-04-13 2026-04-13 PrS Proposed sale
1.6
David Henry

Officer

Officer
3,953
0.71
US$2,807 		3,953 0.71 US$2,807
2026-03-17 2026-03-16 B Purchase
3.6
Getz Heather C
Non-Executive Director
20,000 +17.9%
0.70
US$13,972 		20,000 +17.9% 0.70 US$13,972
2026-03-16 2026-03-13 B Purchase
2.7
KIRK THOMAS F
Non-Executive Director
72,000 +14.9%
0.71
US$51,113 		72,000 +14.9% 0.71 US$51,113
2026-03-12 2026-03-12 B Purchase
3.6
Getz Heather C
Non-Executive Director
70,000 +167.6%
0.73
US$50,960 		70,000 +167.6% 0.73 US$50,960
2025-11-24 2025-11-21 B Purchase
2.7
KIRK THOMAS F
Non-Executive Director
2,535 +0.5%
0.72
US$1,825 		2,535 +0.5% 0.72 US$1,825
2025-11-24 2025-11-20 B Purchase
2.7
KIRK THOMAS F
Non-Executive Director
4,902 +1.0%
0.72
US$3,529 		4,902 +1.0% 0.72 US$3,529
2025-11-21 2025-11-19 B Purchase
3.2
Crowley Thomas Aloysius Jr.
Non-Executive Director
385 +409.6%
0.77
US$295 		385 +409.6% 0.77 US$295
2025-11-21 2025-11-18 B Purchase
3.2
Crowley Thomas Aloysius Jr.
Non-Executive Director
4,000 +5.6%
0.73
US$2,938 		4,000 +5.6% 0.73 US$2,938
2025-08-26 2025-08-25 B Purchase
2.7
KIRK THOMAS F
Non-Executive Director
50,000 +11.8%
1.15
US$57,500 		50,000 +11.8% 1.15 US$57,500
2025-08-19 2025-08-18 B Purchase
2.7
KIRK THOMAS F
Non-Executive Director
50,000 +13.4%
1.10
US$55,000 		50,000 +13.4% 1.10 US$55,000
2025-08-18 2025-08-15 B Purchase
3.6
GUDONIS PAUL R

Chief Executive Officer

Executive Director
50,000 +4.1%
0.95
US$47,295 		50,000 +4.1% 0.95 US$47,295
2025-06-06 2025-06-06 PrS Proposed sale
3.5
Harry Kovelman

Officer

Officer
5,743
2.97
US$17,057 		5,743 2.97 US$17,057
2025-06-06 2025-06-06 PrS Proposed sale
1.6
David Henry

Officer

Officer
8,373
2.97
US$24,868 		8,373 2.97 US$24,868
2025-05-15 2025-05-15 B Purchase
2.7
KIRK THOMAS F
Non-Executive Director
36,824 +12.0%
3.25
US$119,678 		36,824 +12.0% 3.25 US$119,678
2025-05-15 2025-05-15 B Purchase
3.6
GUDONIS PAUL R

Chief Executive Officer

Executive Director
30,000 +2.9%
3.22
US$96,612 		30,000 +2.9% 3.22 US$96,612
2026-05-15 2025-05-14 S Sale
3.3
Mitchell Micah

Chief Commercial Officer

Officer
90,231 -45.2%
0.86
US$77,689 		90,231 -45.2% 0.86 US$77,689
2025-05-15 2025-05-14 B Purchase
2.7
KIRK THOMAS F
Non-Executive Director
1,943 +0.6%
3.25
US$6,315 		1,943 +0.6% 3.25 US$6,315
2025-05-14 2025-05-12 B Purchase
2.7
KIRK THOMAS F
Non-Executive Director
50,000 +19.5%
3.35
US$167,500 		50,000 +19.5% 3.35 US$167,500
2025-03-14 2025-03-14 PrS Proposed sale
3.3
MICAH MITCHELL

Officer

Officer
48,000
5.16
US$247,565 		48,000 5.16 US$247,565
2025-03-14 2025-03-14 S Sale
3.3
Mitchell Micah

Chief Commercial Officer

Officer
48,000 -25.5%
5.16
US$247,565 		48,000 -25.5% 5.16 US$247,565
2025-03-14 2025-03-13 B Purchase
2.7
KIRK THOMAS F
Non-Executive Director
7,400 +3.0%
5.00
US$37,000 		7,400 +3.0% 5.00 US$37,000
2025-03-13 2025-03-13 PrS Proposed sale
3.3
Micah Mitchell

Officer

Officer
1,283
5.22
US$6,697 		1,283 5.22 US$6,697
2025-03-13 2025-03-13 PrS Proposed sale
1.6
David Henry

Officer

Officer
2,019
5.22
US$10,539 		2,019 5.22 US$10,539
2025-03-13 2025-03-13 PrS Proposed sale
3.5
Harry Kovelman

Officer

Officer
1,496
5.22
US$7,809 		1,496 5.22 US$7,809
2025-03-13 2025-03-12 S Sale
3.5
Kovelman Harry

Chief Medical Officer

Officer
30,000 -23.4%
5.50
US$165,018 		30,000 -23.4% 5.50 US$165,018
2025-03-12 2025-03-12 PrS Proposed sale
3.5
HARRY KOVELMAN

Officer

Officer
30,000
5.50
US$165,015 		30,000 5.50 US$165,015
2024-11-04 2024-11-04 PrS Proposed sale
3.5
Harry Kovelman

Officer

Officer
121
3.70
US$448 		121 3.70 US$448
2024-10-03 2024-10-03 PrS Proposed sale
3.5
Harry Kovelman

Officer

Officer
121
3.86
US$467 		121 3.86 US$467
2024-09-09 2024-09-05 S Sale
3.5
Kovelman Harry

Chief Medical Officer

Officer
6,700 -5.1%
3.76
US$25,183 		6,700 -5.1% 3.76 US$25,183
2024-09-04 2024-09-04 PrS Proposed sale
3.5
Harry Kovelman

Officer

Officer
139
3.89
US$541 		139 3.89 US$541
2024-09-05 2024-09-03 S Sale
3.5
Kovelman Harry

Chief Medical Officer

Officer
2,029 -1.5%
4.01
US$8,140 		2,029 -1.5% 4.01 US$8,140
2024-09-03 2024-09-03 PrS Proposed sale
3.5
Harry Kovelman

Officer

Officer
18,500
4.00
US$74,000 		18,500 4.00 US$74,000
2024-08-05 2024-08-05 PrS Proposed sale
3.5
Harry Kovelman

Officer

Officer
128
3.96
US$507 		128 3.96 US$507
2024-07-03 2024-07-03 PrS Proposed sale
3.5
Harry Kovelman

Officer

Officer
121
2.85
US$345 		121 2.85 US$345
2024-07-01 2024-07-01 PrS Proposed sale
1.6
David Henry

Officer

Officer
25,436
3.02
US$76,817 		25,436 3.02 US$76,817
2024-07-01 2024-07-01 PrS Proposed sale
3.3
Micah Mitchell

Officer

Officer
15,500
3.02
US$46,810 		15,500 3.02 US$46,810
2024-07-01 2024-07-01 PrS Proposed sale
3.5
Harry Kovelman

Officer

Officer
12,868
3.02
US$38,861 		12,868 3.02 US$38,861
2024-06-10 2024-06-10 PrS Proposed sale
3.5
Harry Kovelman

Officer

Officer
5,340
3.39
US$18,103 		5,340 3.39 US$18,103
2024-06-10 2024-06-10 PrS Proposed sale
3.3
Micah Mitchell

Officer

Officer
6,824
3.39
US$23,133 		6,824 3.39 US$23,133
2024-06-10 2024-06-10 PrS Proposed sale
1.6
David Henry

Officer

Officer
10,599
3.39
US$35,931 		10,599 3.39 US$35,931
2024-06-03 2024-06-03 PrS Proposed sale
3.5
Harry Kovelman

Officer

Officer
121
3.41
US$413 		121 3.41 US$413
2024-05-31 2024-05-29 B Purchase
2.7
KIRK THOMAS F
Non-Executive Director
50,000 +26.8%
3.50
US$175,000 		50,000 +26.8% 3.50 US$175,000
2024-05-17 2024-05-15 S Sale
3.5
Kovelman Harry

Chief Medical Officer

Officer
35,426 -26.5%
3.69
US$130,839 		35,426 -26.5% 3.69 US$130,839
2024-05-15 2024-05-15 PrS Proposed sale
3.5
HARRY KOVELMAN

Officer

Officer
35,426
3.69
US$130,835 		35,426 3.69 US$130,835
2024-05-03 2024-05-03 PrS Proposed sale
3.5
Harry Kovelman

Officer

Officer
146
3.92
US$572 		146 3.92 US$572
2024-04-02 2024-04-03 PrS Proposed sale
3.5
Harry Kovelman

Officer

Officer
146
3.03
US$442 		146 3.03 US$442
2024-03-18 2024-03-14 B Purchase
2.7
KIRK THOMAS F
Non-Executive Director
50,000 +36.6%
3.50
US$175,000 		50,000 +36.6% 3.50 US$175,000
2024-03-11 2024-03-11 PrS Proposed sale
3.5
Harry Kovelman

Officer

Officer
6,590
3.19
US$21,022 		6,590 3.19 US$21,022
2024-03-11 2024-03-11 PrS Proposed sale
1.6
David Henry

Officer

Officer
7,774
3.19
US$24,799 		7,774 3.19 US$24,799
2024-03-11 2024-03-11 PrS Proposed sale
3.3
Micah Mitchell

Officer

Officer
5,359
3.19
US$17,095 		5,359 3.19 US$17,095
2024-03-04 2024-03-04 PrS Proposed sale
3.5
Harry Kovelman

Officer

Officer
151
3.86
US$583 		151 3.86 US$583
2024-02-02 2024-02-05 PrS Proposed sale
3.5
Harry Kovelman

Officer

Officer
146
3.40
US$496 		146 3.40 US$496
2024-01-02 2024-01-03 PrS Proposed sale
3.5
Harry Kovelman

Officer

Officer
145
4.79
US$695 		145 4.79 US$695
Explore more

More insider trading research around Myomo Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America